• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Branched fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Branched fatty acids

3,4-Dimethylpent-3-enoic Acid (CAS No. 14472-55-0): A Comprehensive Overview

3,4-Dimethylpent-3-enoic acid (CAS No. 14472-55-0) is a unique organic compound that has garnered significant attention in the fields of organic chemistry, biochemistry, and pharmaceutical research. This compound, characterized by its distinct molecular structure and properties, has shown promise in various applications, from synthetic intermediates to potential therapeutic agents. This comprehensive overview aims to provide a detailed understanding of 3,4-dimethylpent-3-enoic acid, including its chemical properties, synthesis methods, biological activities, and recent research developments.

Chemical Properties and Structure

3,4-Dimethylpent-3-enoic acid is a conjugated unsaturated carboxylic acid with the molecular formula C₇H₁₂O₂. The compound features a five-carbon backbone with two methyl groups attached at the third and fourth positions, and a double bond between the third and fourth carbon atoms. The presence of the carboxylic acid group imparts acidic properties to the molecule, making it reactive in various chemical reactions. The conjugated double bond also contributes to the compound's stability and reactivity in different chemical environments.

The physical properties of 3,4-dimethylpent-3-enoic acid include a melting point of approximately 60°C and a boiling point of around 180°C under reduced pressure. It is slightly soluble in water but highly soluble in organic solvents such as ethanol and acetone. These solubility characteristics make it suitable for use in both aqueous and organic reaction media.

Synthesis Methods

The synthesis of 3,4-dimethylpent-3-enoic acid can be achieved through several routes, each with its own advantages and limitations. One common method involves the aldol condensation of acetone with acetaldehyde followed by oxidation to form the carboxylic acid. This process typically involves the use of a base catalyst such as sodium hydroxide or potassium hydroxide to facilitate the condensation reaction. The resulting aldol product is then oxidized using an oxidizing agent like potassium permanganate or sodium hypochlorite to yield 3,4-dimethylpent-3-enoic acid.

An alternative synthetic route involves the Wittig reaction between an aldehyde and a ylide derived from triphenylphosphine and an alkyl halide. This method provides a more controlled approach to forming the double bond at the desired position. The resulting alkene is then oxidized to form the carboxylic acid using standard oxidation protocols.

Biological Activities and Applications

3,4-Dimethylpent-3-enoic acid has been studied for its potential biological activities and applications in various fields. Recent research has shown that this compound exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest that 3,4-dimethylpent-3-enoic acid could be a valuable lead compound for developing new anti-inflammatory drugs.

In addition to its anti-inflammatory effects, 3,4-dimethylpent-3-enoic acid has also been investigated for its potential as an antimicrobial agent. Studies have demonstrated that it possesses significant antibacterial activity against both Gram-positive and Gram-negative bacteria. The mechanism of action is thought to involve disruption of bacterial cell membranes, leading to cell death. This property makes it a promising candidate for developing new antibiotics to combat drug-resistant bacterial strains.

Clinical Trials and Therapeutic Potential

The therapeutic potential of 3,4-dimethylpent-3-enoic acid is currently being explored through preclinical studies and early-stage clinical trials. Preliminary results from these studies have shown promising outcomes in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (IBD). The compound's ability to modulate inflammatory pathways without causing significant side effects makes it an attractive candidate for further development.

In addition to its anti-inflammatory properties, ongoing research is also investigating the potential of 3,4-dimethylpent-3-enoic acid in treating metabolic disorders such as diabetes and obesity. Preclinical studies have shown that it can improve insulin sensitivity and reduce lipid accumulation in adipose tissue. These findings suggest that it could be developed into a novel therapeutic agent for managing metabolic disorders.

Safety Considerations and Future Directions

The safety profile of 3,4-dimethylpent-3-enoic acid is an important consideration for its potential therapeutic applications. Preclinical toxicity studies have indicated that it is generally well-tolerated at therapeutic doses, with no significant adverse effects observed in animal models. However, further clinical trials are necessary to fully evaluate its safety and efficacy in human subjects.

In conclusion, 3,4-dimethylpent-3-enoic acid (CAS No. 14472-55-0) is a versatile compound with a wide range of potential applications in both chemical synthesis and pharmaceutical research. Its unique chemical structure and biological activities make it an exciting area of study for researchers aiming to develop new therapeutic agents for various diseases. As research continues to advance, it is likely that new insights into the properties and applications of this compound will emerge, further expanding its utility in the scientific community.

• 85391-92-0(3,6-Octadienoic acid,3,7-dimethyl-)
• 87919-76-4(3-Hexenoic acid, 3,4-dimethyl-)
• 826-13-1(2-Cyclohepten-1-ol,1-acetate)
• 62444-16-0(3-Decenoic acid, 3-hexyl-, (Z)-)
• 56900-24-4( )
• 85916-85-4(3,6-Octadienoic acid, 3,7-dimethyl-, (3Z)-)
• 143851-50-7(3-Hexenoic acid, 3-methyl-, (Z)-)
• 35205-77-7((3E)-3-methylnon-3-enoic acid)
• 143851-49-4(3-Hexenoic acid, 3-methyl-, (E)-)
• 16313-37-4(3-Pentenoic acid, 3-methyl-)